Cite

HARVARD Citation

    Dreyling, M. et al. (n.d.). EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. Hematological oncology. pp. 387-389. [Online]. 
  
Back to record